QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (115) Citing Articles via Google Scholar Google Scholar Articles by Benmansour, S. Articles by Frazer, A. Search for Related Content PubMed PubMed Citation Articles by Benmansour, S. Articles by Frazer, A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Antidepressants Hazardous Substances DB DESIPRAMINE SERTRALINE

 Previous Article  |  Next Article 

The Journal of Neuroscience, December 1, 1999, 19(23):10494-10501

Effects of Chronic Antidepressant Treatments on Serotonin Transporter Function, Density, and mRNA Level

Saloua Benmansour¹, Marco Cecchi¹, David A. Morilak¹, Greg A. Gerhardt⁴, Martin A. Javors^{1, 2}, Georgianna G. Gould¹, and Alan Frazer^{1, 3}

Departments of ¹ Pharmacology and ² Psychiatry, University of Texas Health Science Center, San Antonio, Texas 78284, ³ South Texas Veterans Health Care System, San Antonio, Texas 78284, and ⁴ Departments of Anatomy and Neurobiology, University of Kentucky, Lexington, Kentucky 40536

To investigate functional changes in the brain serotonin transporter (SERT) after chronic antidepressant treatment, several techniques were used to assess SERT activity, density, or its mRNA content. Rats were treated by osmotic minipump for 21 d with the selective serotonin reuptake inhibitors (SSRIs) paroxetine or sertraline, the selective norepinephrine reuptake inhibitor desipramine (DMI), or the monoamine oxidase inhibitor phenelzine. High-speed in vivo electrochemical recordings were used to assess the ability of the SSRI fluvoxamine to modulate the clearance of locally applied serotonin in the CA3 region of hippocampus in drug- or vehicle-treated rats. Fluvoxamine decreased the clearance of serotonin in rats treated with vehicle, DMI, or phenelzine but had no effect on the clearance of serotonin in SSRI-treated rats. SERT density in the CA3 region of the hippocampus of the same rats, assessed by quantitative autoradiography with tritiated cyanoimipramine ([³H]CN-IMI), was decreased by 80-90% in SSRI-treated rats but not in those treated with phenelzine or DMI. The serotonin content of the hippocampus was unaffected by paroxetine or sertraline treatment, ruling out neurotoxicity as a possible explanation for the SSRI-induced decrease in SERT binding and alteration in 5-HT clearance. Levels of mRNA for the SERT in the raphe nucleus were also unaltered by chronic paroxetine treatment. Based on these results, it appears that the SERT is downregulated by chronic administration of SSRIs but not other types of antidepressants; furthermore, the downregulation is not caused by decreases in SERT gene expression.

Key words: serotonin transporter; antidepressants; in vivo electrochemistry; [³H]CN-IMI binding; mRNA for the SERT; dorsal hippocampus

---

Copyright © 1999 Society for Neuroscience  0270-6474/99/192310494-08$05.00/0

This article has been cited by other articles:

				T. Lau, S. Horschitz, S. Berger, D. Bartsch, and P. Schloss Antidepressant-induced internalization of the serotonin transporter in serotonergic neurons FASEB J, June 1, 2008; 22(6): 1702 - 1714. [Abstract] [Full Text] [PDF]

				N. M. Sanders, C. W. Wilkinson, G. J. Taborsky Jr., S. Al-Noori, W. Daumen, A. Zavosh, and D. P. Figlewicz The selective serotonin reuptake inhibitor sertraline enhances counterregulatory responses to hypoglycemia Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E853 - E860. [Abstract] [Full Text] [PDF]

				Z. Bhagwagar, N. Murthy, S. Selvaraj, R. Hinz, M. Taylor, S. Fancy, P. Grasby, and P. Cowen 5-HTT Binding in Recovered Depressed Patients and Healthy Volunteers: A Positron Emission Tomography Study With [11C]DASB Am J Psychiatry, December 1, 2007; 164(12): 1858 - 1865. [Abstract] [Full Text] [PDF]

				M. Ichise, D. C. Vines, T. Gura, G. M. Anderson, S. J. Suomi, J. D. Higley, and R. B. Innis Effects of early life stress on [11C]DASB positron emission tomography imaging of serotonin transporters in adolescent peer- and mother-reared rhesus monkeys. J. Neurosci., April 26, 2006; 26(17): 4638 - 4643. [Abstract] [Full Text] [PDF]

				R. V. Parsey, R. S. Hastings, M. A. Oquendo, Y.-y. Huang, N. Simpson, J. Arcement, Y. Huang, R. T. Ogden, R. L. Van Heertum, V. Arango, et al. Lower Serotonin Transporter Binding Potential in the Human Brain During Major Depressive Episodes Am J Psychiatry, January 1, 2006; 163(1): 52 - 58. [Abstract] [Full Text] [PDF]

				D. J. Samuvel, L. D. Jayanthi, N. R. Bhat, and S. Ramamoorthy A Role for p38 Mitogen-Activated Protein Kinase in the Regulation of the Serotonin Transporter: Evidence for Distinct Cellular Mechanisms Involved in Transporter Surface Expression J. Neurosci., January 5, 2005; 25(1): 29 - 41. [Abstract] [Full Text] [PDF]

				N. C. Taylor, A. Li, A. Green, H. C. Kinney, and E. E. Nattie Chronic fluoxetine microdialysis into the medullary raphe nuclei of the rat, but not systemic administration, increases the ventilatory response to CO2 J Appl Physiol, November 1, 2004; 97(5): 1763 - 1773. [Abstract] [Full Text] [PDF]

				J. H. Meyer, A. A. Wilson, S. Sagrati, D. Hussey, A. Carella, W. Z. Potter, N. Ginovart, E. P. Spencer, A. Cheok, and S. Houle Serotonin Transporter Occupancy of Five Selective Serotonin Reuptake Inhibitors at Different Doses: An [11C]DASB Positron Emission Tomography Study Am J Psychiatry, May 1, 2004; 161(5): 826 - 835. [Abstract] [Full Text] [PDF]

				C. Andriamampandry, C. Muller, C. Schmidt-Mutter, S. Gobaille, M. Spedding, D. Aunis, and M. Maitre Mss4 Gene Is Up-Regulated in Rat Brain after Chronic Treatment with Antidepressant and Down-Regulated When Rats Are Anhedonic Mol. Pharmacol., December 1, 2002; 62(6): 1332 - 1338. [Abstract] [Full Text] [PDF]

				S. Benmansour, W. A. Owens, M. Cecchi, D. A. Morilak, and A. Frazer Serotonin Clearance In Vivo Is Altered to a Greater Extent by Antidepressant-Induced Downregulation of the Serotonin Transporter than by Acute Blockade of this Transporter J. Neurosci., August 1, 2002; 22(15): 6766 - 6772. [Abstract] [Full Text] [PDF]

				S. W. Kim, S. Y. Park, and O. Hwang Up-Regulation of Tryptophan Hydroxylase Expression and Serotonin Synthesis by Sertraline Mol. Pharmacol., April 1, 2002; 61(4): 778 - 785. [Abstract] [Full Text] [PDF]

				A. L. Bauman, S. Apparsundaram, S. Ramamoorthy, B. E. Wadzinski, R. A. Vaughan, and R. D. Blakely Cocaine and Antidepressant-Sensitive Biogenic Amine Transporters Exist in Regulated Complexes with Protein Phosphatase 2A J. Neurosci., October 15, 2000; 20(20): 7571 - 7578. [Abstract] [Full Text] [PDF]

				J. J. Mann, Y.-y. Huang, M. D. Underwood, S. A. Kassir, S. Oppenheim, T. M. Kelly, A. J. Dwork, and V. Arango A Serotonin Transporter Gene Promoter Polymorphism (5-HTTLPR) and Prefrontal Cortical Binding in Major Depression and Suicide Arch Gen Psychiatry, August 1, 2000; 57(8): 729 - 738. [Abstract] [Full Text] [PDF]

				G. A. Ordway Searching for the Chicken's Egg in Transporter Gene Polymorphisms Arch Gen Psychiatry, August 1, 2000; 57(8): 739 - 740. [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help